公開研究報告

Amazon.com, Inc.

AMZNNASDAQ

增持

Initiate a phased Overweight allocation in Amazon.com, Inc. between $260.00 and $262.50, scaling into support down to $248.00 to capture secular AWS and cloud monetization.

SELLAS Life Sciences Group, Inc.

SLSNASDAQ

持有

Hold current position in SLS; await definitive GPS Phase 3 readout or technical breakout/breakdown for adjustment.

Climb Bio, Inc.

CLYMNASDAQ

持有

Hold current position with disciplined price-based contingencies and catalyst-driven reassessment.

New Era Energy & Digital, Inc.

NUAINASDAQ

持有

Hold current position; add only upon verified PPA or construction commencement with milestones.

Mega Fortune Company Limited

MGRTNASDAQ

賣出

Exit all existing MGRT positions immediately; do not initiate new long exposure under any circumstance.

AXT, Inc.

AXTINASDAQ

持有

Hold current position with strict $85.00 stop-loss and await October 29 earnings for definitive thesis confirmation.

BUUU Group Limited Class A

BUUUNASDAQ

賣出

Sell all BUUU exposure immediately; do not initiate new long positions.

Shattuck Labs, Inc.

STTKNASDAQ

持有

Hold current exposure to STTK, awaiting Q3 2026 Phase 2b trial initiation as the decisive inflection point.

Relmada Therapeutics Inc

RLMDNASDAQ

持有

Hold existing RLMD position; await confirmed breakout above $5.09 or new insider purchases above $4.50 before adjusting exposure.

Q32 Bio Inc

QTTBNASDAQ

持有

閱讀報告

Erasca, Inc.

ERASNASDAQ

持有

Hold current position with partial profit-taking near $19.56 and a dynamic trailing stop starting at $17.49.

D

Damora Therapeutics, Inc.

DMRANASDAQ

持有

Hold current position; await Phase 1/2 data readouts in late 2026–early 2027 before reassessing.

XMAX, Inc.

XMAXNASDAQ

持有

Hold current position; await Q3 earnings or Aerora integration update before adjusting exposure.

Relay Therapeutics, Inc.

RLAYNASDAQ

持有

Hold current position pending resolution of Zovega Phase 3 data, NCCN inclusion, or ReDiscover-2 updates.

Seagate Technology Holdings PLC

STXNASDAQ

持有

Hold current position; await Q1 2027 earnings for resolution of symmetric bull/bear evidence.

Palantir Technologies Inc. Class A

PLTRNASDAQ

減持

Underweight PLTR: trim into the post-earnings strength, retain a measured core, and do not add at the current extended valuation.

L

Lumentum Holdings, Inc.

LITENASDAQ

減持

Underweight LITE: trim oversized exposure now and wait for post-earnings proof of durable growth and cash conversion before rebuilding.

Broadcom Inc.

AVGONASDAQ

減持

Underweight AVGO: trim approximately 25% of a full benchmark position at current levels, retain a 75% core, and wait for either a controlled reset or stronger post-earnings confirmation before adding.